Paul H. Klingenstein, Director, 10% Owner at Conatus Pharmaceuticals Inc (CNAT), sold 566 shares at $11.00 ($6K) on 2013-07-30, disclosed to the SEC on 2013-08-01.
Open-market sale of $6k CNAT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 14 | $154 | 2.5% |
| 2 | $11.00 | 552 | $6K | 97.5% |
| Total | $11.00 avg | 566 | $6K | 100% |
| Filing → |
| ETRM | BUY | 2009-02-25 | $1.4M | — | Filing → |
| ETRM | BUY | 2008-06-03 | $207K | — | Filing → |
| ETRM | BUY | 2008-05-28 | $113K | — | Filing → |